| Literature DB >> 20920328 |
Gillian H Stresman1, Aniset Kamanga, Petros Moono, Harry Hamapumbu, Sungano Mharakurwa, Tamaki Kobayashi, William J Moss, Clive Shiff.
Abstract
BACKGROUND: Asymptomatic reservoirs of malaria parasites are common yet are difficult to detect, posing a problem for malaria control. If control programmes focus on mosquito control and treatment of symptomatic individuals only, malaria can quickly resurge if interventions are scaled back. Foci of parasite populations must be identified and treated. Therefore, an active case detection system that facilitates detection of asymptomatic parasitaemia and gametocyte carriers was developed and tested in the Macha region in southern Zambia.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20920328 PMCID: PMC2959066 DOI: 10.1186/1475-2875-9-265
Source DB: PubMed Journal: Malar J ISSN: 1475-2875 Impact factor: 2.979
Figure 1Macha, Zambia Study Area: Location of Case and Control Homesteads. The map shows the elevation and major river systems of the Macha study region as derived from a digital elevation model. The rural health centres in the area are shown (red cross). The active case detection system focused on the Nalube, Chilalantambo, Mapanza, and Chitongo health centres. The location of the homesteads included in the active case detection system in the Choma (pink) and Namwala (blue) districts and the randomly selected control homesteads (green) are also shown.
Primer sequences for asexual P. falciparum DNA detection
| Target: CYT-B (will detect all species of human | ||
|---|---|---|
| Primary (GCD) | F | 5' CGG TCG CGT CCG GTA GCG TCT AAT GCC TAG ACG TAT TCC TGA TTA TCC AG 3' |
| R | 5' CGC ATC ACC TCT GGG CCG CGT GTT TGC TTG GGA GCT GTA ATC ATA ATG TG 3' | |
| Nested (PLAS) | F | 5' GAG AAT TAT GGA GTG GAT GGT G 3' |
| R | 5' TGG TAA TTG ACA TCC AAT CC 3' | |
| Target: MSP-2 (will detect | ||
| Primary | F | 5' ATG AAG GTA ATT AAA ACA TTG TCT ATT ATA '3 |
| (M20) | R | 5' CTT TGT TAC CAT CGG TAC ATT CTT '3 |
| Nested (IC) | F | 5' AGA AGT ATG GCA GAA AGT AAK CCT YCT ACT 3' |
| R | 5' GAT TGT AAT TCG GGG GAT TCA GTT TGT TCG 3' | |
Primer sequences for P. falciparum gametocytes using RT-PCR
| Target gene: Pfs25 | ||
|---|---|---|
| Primary | 491(F) | 5'-ATC GAT ATG AAT AAA CTT TAC AGT TTG TTT CT-3' |
| 492 (R) | 5'-GAA TTC TTA CAT TAT AAA AAA GCA TAC TC-3' | |
| Nested | 25-1(F) | 5'-TAA TGC GAA AGT TAC CGT GG-3' |
| 25-2 (R) | 5'-TCC ATC AAC AGC TTT ACA GG-3' | |
Characteristics of the two case study populations.
| Choma | Namwala | ||
|---|---|---|---|
| Total Homesteads Screened | 10 | 13 | |
| Mean no. people screened | 8.7 | 7.6 | |
| per homestead | (median = 8; min = 3, max = 16) | (median = 6; min = 3, max = 19) | |
| N | 87 | 99 | |
| ≤ 5 years old (%) | 20 (23.0) | 26 (26.3) | |
| > 5 years old (%) | 67 (77.0) | 73 (73.7) | |
| Mean age | |||
| ≤ 5 years old (range) | 2.6 (0-5) | 2.5 (0-5) | 0.61 |
| > 5 years old (range) | 22.33 (6-77) | 21.17 (6-69) | |
| Sex, n male (%) | 44 (50.6) | 42 (42.4) | 0.26 |
| ≤ 5 years old | 11 (55.0) | 10 (38.5) | |
| > 5 years old | 33 (49.0) | 32 (43.8) | |
| Reported taking malaria | 0 | 0 | |
| meds in last 2 weeks (%) | |||
| Self reported bed net use (%) | 36/58 (62.1) | 46/60 (76.7) | 0.085 |
| ≤ 5 years old | 10/18 (55.6) | 13/15 (86.7) | 0.07 |
| > 5 years old | 26/40 (65.0) | 33/45 (73.3) | 0.48 |
| Reported ever IRS (%) | 8/86 (9.3) | 0/99 (0) | |
| RDT +ve (%) | 2/87 (2.3) | 3/98 (3.1) | 0.56 |
| ≤ 5 years old | 0/20 (0) | 0/25 (0) | |
| > 5 years old | 2/67 (3.0) | 3/73 (4.1) | 1.0 |
| PCR +ve (%) | 7/87 (8.0) | 6/99 (6.1) | 0.77 |
| ≤ 5 years old | 3/20 (15) | 0/26 (0) | 0.08 |
| > 5 years old | 4/67 (6.0) | 6/73 (8.2) | 0.75 |
| RT-PCR +ve (%) | 2/87 (2.9) | 2/99 (2.0) | 0.64 |
| ≤ 5 years old | 1/20 (5.0) | 0/26 (0) | 0.43 |
| > 5 years old | 1/67 (1.5) | 2/73 (2.7) | 1.0 |
Characteristics of the Choma district case and control study populations
| Case | Control | |
|---|---|---|
| Total Homesteads Screened | 10 | 24 |
| Mean no. people screened per homestead | 8.7 | 5.9 |
| (median = 8, min = 3, max = 16) | (median = 5.5, min = 1, max = 13) | |
| N | 87 | 141 |
| ≤ 5 years old (%) | 20 (23.0) | 33 (23.4) |
| > 5 years old (%) | 67 (77.0) | 108 (76.6) |
| Mean age | ||
| ≤ 5 years old (range) | 2.6 (0-5) | 2.73 (0-5) |
| > 5 years old (range) | 22.33 (6-77) | 25.53 (6-77) |
| Sex, n male (%) | 44 (50.6) | 69 (48.9) |
| ≤ 5 years old | 11 (55.0) | 15 (45.4) |
| > 5 years old | 33 (49.0) | 54 (50.0) |
| Reported taking malaria meds in last 2 weeks n (%) | 0 | 43/141 (30.5) |
| Self reported bed net use (%) | 36/58 (62.1) | 43/129 (33.0) |
| ≤ 5 years old | 10/18 (55.6) | 35/113 (31.0) |
| > 5 years old | 26/40 (65.0) | 8/16 (50.0) |
| Reported ever IRS n (%) | 8/86 (9.3) | 0 |
Results of diagnostic measures for malaria in the pooled case and control study populations
| Case | Control | P-value (Fishers Exact) | |
|---|---|---|---|
| RDT +ve (%) | 2/87 (2.3) | 1/141 (0.7) | 0.56 |
| ≤ 5 years old | 0/20 (0) | 1/33 (3.0) | 0.434 |
| > 5 years old | 2/67 (3.0) | 0/108 (0) | 0.07 |
| PCR +ve (%) | 7/87 (8.0) | 1/141 (0.71) | 0.006 |
| ≤ 5 years old | 3/20 (15.0) | 1/33 (3.0) | 0.145 |
| > 5 years old | 4/67 (6.0) | 0/108 (0) | 0.02 |
| RT-PCR +ve (%) | 2/87 (2.3) | 0/141 (0) | 0.145 |
| ≤ 5 years old | 1/20 (5.0) | 0/33 (0) | 0.195 |
| > 5 years old | 1/67 (1.5) | 0/108 (0) | 0.202 |